Information about Oeuvre Belge Du Cancer
My details
*
*
*

Oeuvre Belge Du Cancer (ASBL)

Company information

Status
Active

Enterprise number

BE0457.127.049

VAT liability
No
Established
04-09-1995
Last balance sheet year
2024
Company size
Micro 0 FTE
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Oeuvre Belge Du Cancer

2024 2023 2022 2021
Gross margin 471 -51 % 953 97 % 484 41 % 344

Publications from Oeuvre Belge Du Cancer

Date Publication
06-11-2025 Resignations, Appointments (FR)
18-07-2025 Resignations, Appointments (FR)
02-07-2024 Resignations, Appointments (FR)
08-03-2024 Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
05-09-2022 Resignations, Appointments (FR)

Frequently asked questions

What is the enterprise number of Oeuvre Belge Du Cancer?
The enterprise number of Oeuvre Belge Du Cancer is BE 0457.127.049.
Wat is the PEPPOL ID of Oeuvre Belge Du Cancer?
There is no information available about the PEPPOL ID of Oeuvre Belge Du Cancer or the company is not yet registered on the PEPPOL network.
When was Oeuvre Belge Du Cancer founded?
Oeuvre Belge Du Cancer was founded on 04-09-1995.
What is the address of Oeuvre Belge Du Cancer?
The current registered office of Oeuvre Belge Du Cancer is located at Chaussée de Louvain 479, 1030 Schaerbeek.
When was the last time Oeuvre Belge Du Cancer filed their annual financial statements?
The most recent financial statements of Oeuvre Belge Du Cancer were filed on 28-04-2025.
How many employees does Oeuvre Belge Du Cancer have?
There are currently no employees working at Oeuvre Belge Du Cancer or no workforce information is available.
What is the annual turnover of Oeuvre Belge Du Cancer?
At the time of its most recent financial statements, Oeuvre Belge Du Cancer did not publish any turnover figures. Oeuvre Belge Du Cancer reported a gross margin of €471.21.